The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies-Reference-Cited by-同舟云学术

The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies

Published:2019-06-27 Issue:12 Volume:29 Page:6519-6528
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Li Jiangfa^ORCID,Wang Jiming,Lei Liping,Yuan Guandou,He Songqing

Funder

the State Key Program of National Natural Science Foundation of China

the National Natural Science Foundation of China

111 Project

the National Institutes of Health

Guangxi BaGui Scholars, Project of Guangxi Health and Family Planning Commission

the Project of Guangxi University Collaborative Innovation Center, the project to improve middle-aged and young teachers’ basic ability in Universities of Guangxi

Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-019-06294-6.pdf

Reference31 articles.

1. Manini MA, Sangiovanni A, Fornari F et al (2014) Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. J Hepatol 60(5):995–1001

2. Kim HD, Lim YS, Han S et al (2015) Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. Gastroenterology. 148(7):1371–1382

3. Pascolo L, Cupelli F, Anelli PL et al (1999) Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun 257(3):746–752

4. Yoo SH, Choi JY, Jang JW et al (2013) Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma. Ann Surg Oncol 20(9):2893–2900